Compounds > metronidazole

metronidazole and surotomycin

metronidazole has been researched along with surotomycin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL1
Bouillaut, L; Chesnel, L; Mascio, C; McBride, S; Schmidt, DJ; Sonenshein, AL; Sorg, JA; Suarez, JM; Tzipori, S1
Cadnum, JL; Chan, L; Chesnel, L; Deshpande, A; Donskey, CJ; Gao, L; Hurless, K; Kundrapu, S; Polinkovsky, A1
Alam, MJ; Bassères, E; Chesnel, L; Endres, BT; Garey, KW; Khaleduzzaman, M1
Boegli, L; Chesnel, L; deLancey Pulcini, E; Fisher, S; James, GA; Stewart, PS1

Other Studies

5 other study(ies) available for metronidazole and surotomycin

ArticleYear
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Enterobacteriaceae; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Intestines; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin

2012
Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Cell Wall; Clostridioides difficile; Enterotoxins; Gene Expression Regulation, Bacterial; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Spores, Bacterial; Vancomycin; Virulence Factors

2015
Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Female; Gram-Negative Bacteria; Klebsiella pneumoniae; Lipopeptides; Metronidazole; Mice; Peptides, Cyclic; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci

2016
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Enterotoxins; Humans; Interleukin-8; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peptides, Cyclic; Vancomycin

2016
Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Biofilms; Biological Transport; Clostridioides difficile; Colony Count, Microbial; Fidaxomicin; Humans; Lipopeptides; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peptides, Cyclic; Spores, Bacterial; Vancomycin

2018